The DOI matches its Crossref record; 107 of the 108 references it cites were found in a registry or an index, and 1 are not checked yet.
Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis
Open accessAbstract
The diagnosis of amyotrophic lateral sclerosis can be challenging due to its heterogeneity in clinical presentation and overlap with other neurological disorders. Diagnosis early in the disease course can improve outcomes as timely interventions can slow disease progression. An evolving awareness of disease genotypes and phenotypes and new diagnostic criteria, such as the recent Gold Coast criteria, could expedite diagnosis. Improved prognosis, such as that achieved with the survival model from the European Network for the Cure of ALS, could inform the patient and their family about disease course and improve end-of-life planning. Novel staging and scoring systems can help monitor disease progression and might potentially serve as clinical trial outcomes. Lastly, new tools, such as fluid biomarkers, imaging modalities, and neuromuscular electrophysiological measurements, might increase diagnostic and prognostic accuracy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“monogenic ALS mutations may still exhibit incomplete penetrance or delayed onset [8]”
From Lifestyle and medical conditions in relation to ALS risk and progression—an introduction to the Swedish ALSrisc Study (2024) · cites this paper as [8]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“as exposure to certain environmental factors might modify the risk the mutations confer [8].”
From Lifestyle and medical conditions in relation to ALS risk and progression—an introduction to the Swedish ALSrisc Study (2024) · cites this paper as [8]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis
Brooks, B. R., Miller, R. G., Swash, M., & Munsat, T. L. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608200300079536 · Cited by 5,433
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409
Self-citationCedarbaum, J. M., Stambler, N., Malta, E., Fuller, C., Hilt, D., Thurmond, B., & Nakanishi, A. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00210-5 · Cited by 3,307
Strong, M. J., Abrahams, S., Goldstein, L. H., Woolley, S., Mclaughlin, P., Snowden, J., Mioshi, E., Roberts-South, A., Benatar, M., HortobáGyi, T., et al. (2017) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2016.1267768 · Cited by 909
Chiò, A., Logroscino, G., Traynor, B. J., Collins, J., Simeone, J. C., Goldstein, L. A., & White, L. A. (2013) · Neuroepidemiology · doi:10.1159/000351153 · Cited by 862
Self-citationThe phenotypic variability of amyotrophic lateral sclerosis
Swinnen, B., & Robberecht, W. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.184 · Cited by 647
Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study
Chiò, A., Calvo, A., Moglia, C., Mazzini, L., Mora, G., & PARALS study group (2011) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.235952 · Cited by 626
Self-citationA proposal for new diagnostic criteria for ALS
Shefner, J. M., Al‐Chalabi, A., Baker, M. R., Cui, L., de Carvalho, M. A., Eisen, A., Großkreutz, J., Hardiman, O. M., Henderson, R. D., Matamala, J. M., et al. (2020) · Clinical Neurophysiology · doi:10.1016/j.clinph.2020.04.005 · Cited by 622
Self-citationNovel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications
Chia, R., Chiò, A., & Traynor, B. J. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30401-5 · Cited by 592
Self-citation
Research works printed but not linked: 1
- Pinto-Grau, 2020, Patterns of language impairment in early ALS, Neurol Clin Pract, 11, e634
Cited by
Sorted by citations
Items 201–300 of 493
Li, Y., Feng, Y., Liu, X., Yuan, R., Chen, S., Wang, J., Pan, C., Li, G., & Tang, Z. (2026) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00595 · Cited by 4
The Landscape of Ferritin Nanocages for Neurodegenerative Diseases Treatment
Wen, S., Gao, J., Sun, J., Li, X., Xu, X.-L., & Chen, J. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s571993 · Cited by 4
Luo, Y., Liu, X., & Yang, M. (2026) · Frontiers in Rehabilitation Sciences · doi:10.3389/fresc.2026.1666530 · Cited by 4
Amyotrophic Lateral Sclerosis (ALS) Genetics and Microbiota: A Comprehensive Review
Kurdi, M. A., Alotaibi, H. M., Alkhuraymi, A. T., Aldahery, L. N., Alhawaj, A. F., & Aldali, H. J. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27041978 · Cited by 5
Loss of Splicing Homeostasis as a Hallmark of Aging
Donegà, S., Gorospe, M., Harries, L. W., & Ferrucci, L. (2026) · Molecular and Cellular Biology · doi:10.1080/10985549.2026.2627235 · Cited by 4
ALS motor phenotypes: a revised ‘OPM’ classification
Meyer, T., Ticozzi, N., Weber, M., Ravits, J., Lingor, P., Kuźma‐Kozakiewicz, M., Boentert, M., Grehl, T., Corcia, P., Panadés, M. P., et al. (2026) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2026.2644277 · Cited by 4
Shi, J., Wang, Z., Yi, M., Xie, S., Zhang, X., Tao, D., Liu, Y., & Yang, Y. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1333782 · Cited by 4
Diagnostic utility of threshold tracking TMS paradigms in early amyotrophic lateral sclerosis
Calma, A. D., Pavey, N., Silva, C. S., van den Bos, M. A. J., Yiannikas, C., Farrar, M. A., Kiernan, M. C., Menon, P., & Vucic, S. (2025) · Clinical Neurophysiology · doi:10.1016/j.clinph.2025.03.044 · Cited by 4
Self-citationZhao, Q., Zhang, B., Chen, X., Fu, P., Yang, Y., & Wang, Q. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1641887 · Cited by 5
Gonçalves, L. M. N., Siéssere, S., Cecílio, F. A., Hallak, J. E. C., de Vasconcelos, P. B., Marques, W., Regalo, I. H., Palinkas, M., & Regalo, S. C. H. (2022) · Prague Medical Report · doi:10.14712/23362936.2022.24 · Cited by 4
Amyotrophic lateral sclerosis disease burden: doing better at getting better
Volonté, C., & Amadio, S. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.363193 · Cited by 4
Waller, R., Bury, J. J., Appleby‐Mallinder, C., Wyles, M., Loxley, G., Babel, A., Shekari, S., Kazoka, M., Wollff, H., Al‐Chalabi, A., et al. (2023) · Brain Communications · doi:10.1093/braincomms/fcad331 · Cited by 4
Self-citationFIG4-associated disease manifesting as rapidly progressive amyotrophic lateral sclerosis
Ferreira, V. M., Caetano, A., Santos, L. G., & Fernandes, M. (2024) · Neurological Sciences · doi:10.1007/s10072-024-07542-4 · Cited by 4
Rostás, R., Fekete, I., Horváth, L., Márton, S., & Fekete, K. (2024) · Open Medicine · doi:10.1515/med-2024-0990 · Cited by 4
Howard, I. M., Babu, S., Carter, C. R., Sakowski, S. A., Kurent, J. E., Cudkowicz, M., & Feldman, E. L. (2024) · Annals of Neurology · doi:10.1002/ana.27097 · Cited by 4
Self-citationRawlinson, C. V., Gould, R. L., McDermott, C. J., Thompson, B. T., Weeks, K., Gossage-Worrall, R., Serfaty, M. A., Graham, C. D., McCracken, L. M., White, D. A., et al. (2024) · The Cognitive Behaviour Therapist · doi:10.1017/s1754470x24000333 · Cited by 5
Self-citationUsefulness of the Gold Coast criteria in diagnosing fast-progressing amyotrophic lateral sclerosis
Ohnari, K., Mafune, K., & Adachi, H. (2025) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2025.123418 · Cited by 4
The prognostic value of systematic genetic screening in amyotrophic lateral sclerosis patients
He, D., Liu, Y., Dong, S., Shen, D., Yang, X., Hao, M., Yin, X., He, X., Li, Y., Wang, Y., et al. (2023) · Journal of Neurology · doi:10.1007/s00415-023-12079-1 · Cited by 4
Cai, R., Yang, J., Wu, L., Liu, Y., Wang, X., Zheng, Q., & Li, L. (2024) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-024-03057-5 · Cited by 4
Galvin, M., Heverin, M., Domhnaill, É. M., Mcfarlane, R., Meldrum, D., Murray, D., Bolger, A., Connelly, J., Flynn, K., Fox, E., et al. (2025) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2024.2428927 · Cited by 3
Self-citationNeuroglia in neurodegeneration: Amyotrophic lateral sclerosis and frontotemporal dementia
Marchi, F. D., Spinelli, E. G., & Bendotti, C. (2025) · Handbook of clinical neurology · doi:10.1016/b978-0-443-19102-2.00004-1 · Cited by 4
Correlation between oral microbiota and dry socket at different time periods on tooth extraction
Wu, Y., Lyu, H., Deng, X., Liu, Y., He, Y., & Xu, M. (2025) · Journal of Oral Microbiology · doi:10.1080/20002297.2025.2485210 · Cited by 3
Chau, I., Stoker, E., Gill, J., & Newton, J. L. (2025) · PLoS ONE · doi:10.1371/journal.pone.0319628 · Cited by 3
Asano, H., Kawaguchi, T., Kato, C., Morimoto, S., Yano, M., Minaguchi, M., Yasuda, D., Fukushima, K., & Okano, H. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70183 · Cited by 4
Noninvasive Ventilation Effectiveness in Amyotrophic Lateral Sclerosis
Sancho, J., Ferrer, S., & Signes‐Costa, J. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14238609 · Cited by 3
Bolsinger, M. M., Vivek, N., Singh, J., Challa, A., Zhu, A., Rothell, T., Wang, S., Zhang, T., Zhu, S., Robbins, N., et al. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08562-8 · Cited by 3
Boomsma, A., Doyle, C., Sai, N., Rogers, M., Lee, S., & Benyamin, B. (2026) · Journal of Neurology · doi:10.1007/s00415-026-13627-1 · Cited by 3
Novel extracellular vesicle release pathway facilitated by toxic superoxide dismutase 1 oligomers
Hnath, B., Ekambaram, S., & Dokholyan, N. V. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107309 · Cited by 3
Seo, J., Saurkar, S., Fernandez, G. S., Das, A., Goutman, S. A., & Heidenreich, S. (2023) · Patient · doi:10.1007/s40271-023-00665-4 · Cited by 4
Self-citationThe Implication and Application of Brain Glymphatic System in Multiple Diseases
Du, Y., Yan, C., Wang, Y., Xu, Y., Cun, X., & Gao, H. (2024) · Advanced Therapeutics · doi:10.1002/adtp.202400088 · Cited by 3
Prognostic communication in amyotrophic lateral sclerosis: findings from a Nationwide Italian survey
Moglia, C., Palumbo, F., Botto, R., Iazzolino, B., Ticozzi, N., Calvo, A., Leombruni, P., & MND Study Group of the Italian Society of Neurology (2024) · Neurological Sciences · doi:10.1007/s10072-024-07702-6 · Cited by 3
Overview of nomenclature and diagnosis of amyotrophic lateral sclerosis
Xu, R. (2024) · Annals of Medicine · doi:10.1080/07853890.2024.2422572 · Cited by 3
Graphene Chemeo‐Phononics for Biosensor Applications: An Interfacial Raman Transducer
Keisham, B., Kim, S., Cotts, S., & Berry, V. (2022) · Advanced Materials Interfaces · doi:10.1002/admi.202200773 · Cited by 3
Disease survival and progression in TARDBP ALS patients from Sardinia, Italy
Borghero, G., Pili, F. M. G., Muroni, A., Ercoli, T., Pateri, M. I., Pilotto, S., Maccabeo, A., & Defazio, G. (2023) · Journal of Neurology · doi:10.1007/s00415-023-12037-x · Cited by 3
Rare DNAJC7 Variants May Play a Minor Role in Chinese Patients with ALS
Wang, S., Zheng, X., Wei, Q., Lin, J., Yang, T., Xiao, Y., Jiang, Q., Li, C., & Shang, H. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03677-1 · Cited by 3
Möhwald, L. M., Maier, A., Grehl, T., Weyen, U., Weydt, P., Günther, R., Lingor, P., Göricke, B., Petri, S., Großkreutz, J., et al. (2025) · Neurological Research and Practice · doi:10.1186/s42466-024-00363-y · Cited by 4
Phosphatemia is an Independent Prognostic Factor in Amyotrophic Lateral Sclerosis
Vasta, R., Koumantakis, E., Canosa, A., Manera, U., Grassano, M., Palumbo, F., Cabras, S., Matteoni, E., Pede, F. D., Mattei, F. D., et al. (2025) · Annals of Neurology · doi:10.1002/ana.27252 · Cited by 3
Self-citationChoi, S., Kim, J.-S., Jeong, S. Y., Son, H., Sung, J., Park, C. M., & Choi, K. S. (2025) · Radiology · doi:10.1148/radiol.243463 · Cited by 3
La sclérose latérale amyotrophique : une maladie neurodégénérative emblématique
Viader, F. (2023) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2023.01.002 · Cited by 3
Li, B., Liu, H., Li, C., Yang, M., & Zhang, T. (2023) · Medicine · doi:10.1097/md.0000000000033612 · Cited by 3
González‐Mingot, C., Mena, F. J. M., Iñarrea, P., Íñiguez, C., Capablo, J. L., Osta, R., Gil-Sánchez, A., Peralta, S., Brieva, L., & Larrodé, P. (2023) · Research Square · doi:10.21203/rs.3.rs-2480485/v1 · Cited by 3
Cassel, R., Lorenc, F., Bombardier, A., Tapia, C. D., Dieterle, S., Roque, C. G., Jackson, C. A., Stuart‐Lopez, G., Rouaux, C., Guillot, S. J., et al. (2025) · medRxiv · doi:10.1101/2025.06.16.25329673 · Cited by 4
Self-citationGenotype–phenotype correlation of SQSTM1 variants in patients with amyotrophic lateral sclerosis
Wang, S., Jiang, Q., Zheng, X., Wei, Q., Lin, J., Yang, T., Xiao, Y., Li, C., & Shang, H. (2024) · Journal of Medical Genetics · doi:10.1136/jmg-2023-109569 · Cited by 3
Kim, Y. S., Jong-Hyeop, O., Cho, H., & Ye, S. (2024) · Annals of Occupational and Environmental Medicine · doi:10.35371/aoem.2024.36.e28 · Cited by 2
Treatment of Neurogenic Voice Disorders
Syamal, M. N. (2025) · World Journal of Otorhinolaryngology - Head and Neck Surgery · doi:10.1002/wjo2.70011 · Cited by 2
Bu, Y., Yuan, Y., Hu, F., Zhao, Q., He, C., Tang, L., Li, Y., Liu, Z., Weng, L., Du, J., et al. (2025) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2025.111268 · Cited by 2
Neuhaus, D., Wendebourg, M. J., Deigendesch, N., Berger, C., Bauer, M., Haas, T., Scheurer, E., Schlaeger, R., & Lenz, C. (2025) · NMR in Biomedicine · doi:10.1002/nbm.70059 · Cited by 2
Pavlenko, T. A., Chesnokova, N. B., Валерьевна, Б. О., Shikareva, N. N., Nodel, M. R., Викторовна, Ш. К., Panina, U. V., Shteinberg, D. A., Kukharskaya, O. A., Sukhanova, I. S., et al. (2025) · PeerJ · doi:10.7717/peerj.19623 · Cited by 2
Martinelli, I., Simonini, C., Zucchi, E., Gianferrari, G., Bedin, R., Ghezzi, A., & Mandrioli, J. (2025) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2025.578683 · Cited by 2
Palumbo, F., Iazzolino, B., Moglia, C., Manera, U., Matteoni, E., Cabras, S., Brunetti, M., Gallone, S., Callegaro, S., Vasta, R., et al. (2025) · Journal of Neurology · doi:10.1007/s00415-025-13276-w · Cited by 2
Self-citationHe, Y., Wang, J., Tang, J., Lü, L., Chen, J., Xu, H., Li, X., Zhou, M., Xu, Y., & Wang, X. (2025) · Neuroepidemiology · doi:10.1159/000547389 · Cited by 2
Is amyotrophic lateral sclerosis less severe in mice than in humans?
Dupuis, L., & Robertson, J. (2025) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001412 · Cited by 2
Motor neuron axonal excitability changes in the clinical course of amyotrophic lateral sclerosis
Kokotis, P., Bakola, E., Schmelz, M., Rentzos, M., Papagiannopoupou, G., & Tsivgoulis, G. K. (2025) · Neurological Sciences · doi:10.1007/s10072-025-08443-w · Cited by 2
Logroscino, G., Giannoni‐Luza, S., Urso, D., & Hamdi, N. (2025) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001415 · Cited by 2
Beyond Motor Decline in ALS: Patient-Centered Insights into Non-Motor Manifestations
Moțățăianu, A., Andone, S. R., Maier, S., Chinezu, R., Roman, M., Dumitreasă, M., Bălașa, R., & Ormenișan, I. (2025) · Medicina · doi:10.3390/medicina61091694 · Cited by 2
Schwann cells as a therapeutic target for amyotrophic lateral sclerosis: A TDP-43 focussed review
Lewis, K. N., Gonsalvez, D. G., Turner, B. J., & Barton, S. K. (2025) · Neurochemistry International · doi:10.1016/j.neuint.2025.106055 · Cited by 2
Lee, B., Kuo, Y.-C. J., Cheng, L.-F., Tsai, Y.-C., Huang, J.-Z., Tsai, H.-H., Lin, J.-S., Huang, P.-Y., Ting, C.-H., Yang, C., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199474 · Cited by 2
Stefano, G. B., Büttiker, P., Weissenberger, S., Raboch, J., & Anders, M. (2025) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2025.101217 · Cited by 2
Advances in ALS genetics and emerging precision therapies
Jih, K., Fang, S., & Lee, Y. (2025) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2025.10.032 · Cited by 4
van Wijk, I. F., Kraneburg, L., van Eijk, R. P. A., Veldink, J. H., van Es, M. A., Westeneng, H., & van den Berg, L. H. (2025) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2025.2574687 · Cited by 2
Short prescribed exercises can quantify upper limb functioning in neurodegenerative disease
Strączkiewicz, M., Burke, K. M., Calcagno, N., Premasiri, A. S., Carney, K. T., Vieira, F. G., Onnela, J.-P. “., & Berry, J. D. (2026) · Journal of NeuroEngineering and Rehabilitation · doi:10.1186/s12984-025-01829-z · Cited by 2
Liampas, I., Kimiskidis, V. Κ., Zouvelou, V., Veltsista, D., Moscholouri, A., Triantafyllou, E., Daponte, A., Xirou, S., Sterpi, A.-E., Salakou, S., et al. (2026) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2026.2648293 · Cited by 2
BDNF insufficiency exacerbates ALS progression
Xu, Y., He, J., Wang, S., Ge, Y., Jia, Y., Guo, W., Chen, L., Yao, X., Mao, Y., Mei, F., et al. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102758 · Cited by 2
Multimodal strategies for diagnosis, stratification, and therapeutic monitoring in ALS
López‐Blanch, R., Oriol‐Caballo, M., Estrela, J. M., & Obrador, E. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106727 · Cited by 3
Raymond, J. S., Larson, T., Mohidul, S., Martin-Greene, D., Love, K., Mehta, V., Wymer, J. P., Howard, I. M., Horton, D. K., & Mehta, P. (2026) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2026.2677528 · Cited by 2
Sabetta, E., Rallmann, K., Taba, P., Pfaff, A. L., Poudel, B. H., Ferrari, D., Locatelli, M., Kõks, S., & Bergquist, J. (2026) · Journal of Neurochemistry · doi:10.1111/jnc.70508 · Cited by 2
Moskvin, S. V. (2024) · Biomedicine · doi:10.37796/2211-8039.1430 · Cited by 2
Takotsubo syndrome in a Sardinian amyotrophic lateral sclerosis cohort
Maccabeo, A., Pateri, M. I., Pili, F., Pilotto, S., Pierri, V., Muroni, A., Ercoli, T., Montisci, R., Marchetti, M., Martis, A., et al. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12681-x · Cited by 2
Tkachenko, K., González-Sáiz, J. M., Calvo, A. C., Lunetta, C., Osta, R., & Pizarro, C. (2024) · Biosensors · doi:10.3390/bios14110526 · Cited by 2
Li, R., Bao, T., Li, B., Xia, P., Zhang, T., Zhang, H., & Huang, F. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1519513 · Cited by 2
Sun, C., Chen, Y., Xu, L., Wang, W., Zhang, N., Fournier, C. N., Li, N., & Fan, D. (2025) · Biomedicines · doi:10.3390/biomedicines13010178 · Cited by 2
Radiomic alterations and clinical correlates of hypothalamic nuclei in ALS
Tafuri, B., Giugno, A., Nigro, S. L., Zoccolella, S., Barone, R., Tamburrino, L., Gnoni, V., Urso, D., Rollo, E., Blasi, R. D., et al. (2025) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2025.109906 · Cited by 2
Improving ALS Diagnosis Based on Human EEG Signal Analysis with Machine Learning
Abedi, A., Moradi, G., Shirazi, R. S., & Jahed, M. (2024) · National and International Iranian Conference on Biomedical Engineering (ICBME) · doi:10.1109/icbme64381.2024.10895722 · Cited by 2
Xu, Z., Yi, W., Guan, L., Tang, J., Feng, D., & Zou, Y. F. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00045 · Cited by 2
Douglas, A., McPhee, M., Fisher, F., Cheng, C. C., Henders, A. K., Ziser, L., Stout, J. C., Kiernan, M. C., Osborne, R. H., & Mathers, S. (2025) · BMC Health Services Research · doi:10.1186/s12913-025-12998-x · Cited by 2
Self-citationTang, X., Yuan, Y., Liu, Z., Bu, Y., Tang, L., Zhao, Q., Jiao, B., Guo, J., Shen, L., Jiang, H. F., et al. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1114022 · Cited by 2
Sung, W., Kim, J.-A., Kim, Y. S., Park, J., Oh, K., Sung, J., Kim, Y.-E., Kim, Y.-E., & Kim, S. H. (2023) · Scientific Reports · doi:10.1038/s41598-023-45593-3 · Cited by 2
Mitra, J., Dharmalingam, P., Kodavati, M. M., Guerrero, E. N., Rao, K. S. J., Garruto, R. M., & Hegde, M. L. (2024) · Research Square · doi:10.21203/rs.3.rs-3879966/v2 · Cited by 3
Lateral hypothalamus drives early-onset sleep alterations in amyotrophic lateral sclerosisPreprint
Guillot, S. J., Lang, C., Simonot, M., Knehr, A., Stuart‐Lopez, G., Weydt, P., Dorst, J., Kandler, K., Kassubek, J., Wassermann, L., et al. (2024) · medRxiv · doi:10.1101/2024.08.21.24312343 · Cited by 2
The Beaumont behavioral intervention in a Chinese amyotrophic lateral sclerosis cohort
Jia, H., Li, Z., Liu, H., Ren, M., Liu, T., Zhou, X., Li, X., Li, R., Liu, Q., Liu, Y., et al. (2023) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2023.2271518 · Cited by 1
Gestasyonel Trofoblastik Hastalıklar ve Yönetimi
Taşkum, İ., & Soykan, Y. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub388.c1595 · Cited by 1
Changes in saccadic intrusions over time as an objective biomarker to follow ALS disease progression
Berkman, O., Raveh, E., Harpaz, E., Kreitman, R., Ben-Ami, E., Nechushtan, E., Birman, N., & Drory, V. E. (2024) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2024.2376732 · Cited by 1
Yang, N., Shi, L., Xu, P., Ren, F., Li, C., & Qi, X. (2024) · Experimental Gerontology · doi:10.1016/j.exger.2024.112538 · Cited by 1
Wang, Y., Ju, R., Jiang, J., Mao, L., Li, X., & Deng, M. (2024) · Neurological Sciences · doi:10.1007/s10072-024-07759-3 · Cited by 1
Cell and gene therapy for amyotrophic lateral sclerosis
Paris, A., & Lakatos, A. (2024) · Handbook of clinical neurology · doi:10.1016/b978-0-323-90120-8.00017-4 · Cited by 1
Why is the treatment and management of amyotrophic lateral sclerosis so difficult?
Corcia, P., Piras, R., & Lunetta, C. (2024) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2024.2415002 · Cited by 1
Immunotherapy for Neurodegenerative Movement Disorders
Mosley, R. L., Saleh, M., & Olson, K. E. (2024) · Springer eBooks · doi:10.1007/978-3-031-68237-7_52 · Cited by 1
Novy, C., Tysnes, O., Busk, Ø. L., Jaioun, K., Holmøy, T., Holla, Ø. L., & Høyer, H. (2024) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2024.2447922 · Cited by 1
Hruška, J., Bachmann, P., & Odei, S. A. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2024.1393261 · Cited by 2
RetractedAtypical Facial Onset Weakness in SOD1 ALS
Garret, M. A., Namiranian, D., Milone, M., Varadhachary, A. S., & Ho, D. T. (2025) · Muscle & Nerve · doi:10.1002/mus.28428 · Cited by 1
McDonough, H., McFarlane, R., Puchades, A. C., Chiò, A., Corcia, P., Galvin, M., Heverin, M., Hobin, F., Holmdahl, O., Ingre, C., et al. (2025) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2024.2448536 · Cited by 1
Self-citationUpdates in the Management of Neuromuscular Emergencies
Amoashiy, W., Ocasio, C. G., Patel, J., Nagabushan, S., & Landman, A. (2025) · Current Treatment Options in Neurology · doi:10.1007/s11940-025-00844-8 · Cited by 1
Zhao, J., Bai, J., Wang, H., Zhang, Y., Zhang, J., Zhu, Y., Pang, X., Chen, Z., Li, L., Cheng, H., et al. (2025) · Journal of Electromyography and Kinesiology · doi:10.1016/j.jelekin.2025.103040 · Cited by 1
A case of novel meningoencephalomyelitis associated with vimentin IgG autoantibodies
Sun, Y., Cao, Z., & Li, F. (2026) · BMC Neurology · doi:10.1186/s12883-026-04912-7 · Cited by 1
Biomarker profile of a Chinese ALS cohort: A comprehensive clinical-biomarkers-imaging analysis
Wang, Y., Lin, J., Qu, Y., Ding, Y., Ye, Z., Zhu, Z., Wei, C., Chen, Z., Sun, H., Hu, F., et al. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107059 · Cited by 1
Huang, Y., Wan, Y., Chen, J., Qin, M., Wang, J., & Liang, H. (2025) · Neurodegenerative Disease Management · doi:10.1080/17582024.2025.2554525 · Cited by 1
Macpherson, C. E., Wani, D., Li, H., Rana, V., Blacutt, M. E., Bello-Haas, V. P. M. D., & Quinn, L. (2025) · Physical Therapy · doi:10.1093/ptj/pzaf142 · Cited by 1
Movement Related Beta-Band Modulation with OPM-MEG: A Pilot Study
Stærmose, T. S., Blicher, J. U., & Dalal, S. S. (2025) · Brain Topography · doi:10.1007/s10548-025-01150-x · Cited by 2
Tang, H., Jiang, P., & Chen, J. (2025) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000548720 · Cited by 1
Neuropalliative Care in Neuromuscular Disorders
Oliver, D. J. (2025) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/cont.0000000000001638 · Cited by 1
Metadata
- Authors
- Goutman, S. A., Hardiman, O., Al-Chalabi, A., Chió, A., Savelieff, M. G., Kiernan, M. C., & Feldman, E. L.
- Affiliations
- University of Michigan (US)
- Trinity College Dublin (IE)
- University of Turin (IT)
- The University of Sydney (AU)
- Corresponding author
- Feldman, Eva L
- Venue
- The Lancet Neurology
- Publisher
- Elsevier BV
- Published
- 2022-05
- Volume
- 21
- Issue
- 5
- Pages
- 480-493
- ISSN
- 1474-4422 (ISSN-L)
- PMC
- PMC9513753
- OpenAlex
- W4220676470
- Cited by
- 493
- References
- 107
- Citations by year
- 2026: 115 · 2025: 125 · 2024: 143 · 2023: 82 · 2022: 28
- FWCI
- 13.65
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- The Lancet Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
- Funders
- Seventh Framework Programme (259867)
- National Institute for Health Research Imperial Biomedical Research Centre
- Medical Research Council (MR/R024804/1, MR/L501529/1)
- Science Foundation Ireland (16/RC/3948, 13/RC2015)
- National Institute for Health Research (NIHR202421)
- National Institute of Neurological Disorders and Stroke (R01NS120926, R01NS127188)
- South London and Maudsley NHS Foundation Trust
- Ministero della Salute
- ALS Association
- National Institute of Environmental Health Sciences (R01ES030049, K23ES027221)
- Health Research Board
- National Health and Medical Research Council (APP1132524, APP1153439, APP1156093)
- University of Michigan
- Sinai Medical Staff Foundation
- Thierry Latran Foundation
- Horizon 2020
- Economic and Social Research Council (ES/L008238/1)
- Ministero dell’Istruzione, dell’Università e della Ricerca (2017SNW5MB)
- EU Joint Programme – Neurodegenerative Disease Research
- Motor Neurone Disease Association
- King's College London
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Health Sciences › Medicine › Genetics (clinical) › Neurogenetic and Muscular Disorders Research
- Health Sciences › Medicine › Internal Medicine › Amyloidosis: Diagnosis, Treatment, Outcomes
- Keywords
- amyotrophic lateral sclerosis, diagnosis, prognosis, survival models, disease staging, disease progression, fluid biomarkers, neuroimaging, phenotypes, end-of-life planning
- MeSH terms
- Amyotrophic Lateral Sclerosis, Electromyography, Humans, Prognosis, Biomarkers, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
